LISSONI ANDREA ALBERTO

Post, C., De Boer, S., Powell, M., Mileshkin, L., Katsaros, D., Bessette, P., et al. (2025). Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial. OBSTETRICAL & GYNECOLOGICAL SURVEY, 80(12), 757-759 [10.1097/OGX.0000000000001475]. Detail

Post, C., De Boer, S., Powell, M., Mileshkin, L., Katsaros, D., Bessette, P., et al. (2025). Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial. THE LANCET ONCOLOGY, 26(10), 1370-1381 [10.1016/s1470-2045(25)00379-1]. Detail

Bianchi, T., Grassi, T., De Ponti, E., Jaconi, M., Seca, M., Inzoli, A., et al. (2025). Fertility sparing surgery in patients with advanced borderline ovarian tumors: Oncologic outcomes of a single-institution cohort. GYNECOLOGIC ONCOLOGY, 199(August 2025), 10-16 [10.1016/j.ygyno.2025.06.009]. Detail

Bianchi, T., Grassi, T., Bazzurini, L., Testa, F., Corti, J., Pecis Cavagna, G., et al. (2024). The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 50(9 (September 2024)) [10.1016/j.ejso.2024.108523]. Detail

Marino, G., Grassi, T., De Ponti, E., Negri, S., Testa, F., Giuliani, D., et al. (2024). Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy. FRONTIERS IN ONCOLOGY, 14 [10.3389/fonc.2024.1330481]. Detail